Austco Healthcare Limited (ASX: AHC) is pleased to provide a trading update for the first quarter of FY25,highlighting the Company’s strong performance and continued execution of its growth strategy.
Austco Healthcare’s Q1 organic revenues increased by 16% compared to the prior corresponding period and by 90% when contributions from Teknocorp and Amentco are included.
This underscores the Company’s strong operational performance, noting that the Q1 FY24 period did not include revenue contributions fromTeknocorp and Amentco.
During the quarter, Austco Healthcare announced several major contract wins, including a $5.0 million contract to provide its industry-leading Tacera alarm management and clinical workflow solution for the new Surrey Hospital in Vancouver, British Columbia.
The Company also secured a phase 2 order to expand the Jurong Health Complex contract, bringing its total value to $5.5 million.
Contracted Orders have reached a record $51.1 million, positioning the Company for continued growth.Recent investments in sales and marketing capabilities in high-growth markets have strategically placed the business to capture new opportunities in the expanding healthcare technology sector, driving organic growth.
The recently acquired Teknocorp and Amentco businesses have performed well, delivering strong results,expanded market reach and enhanced product offerings.
These acquisitions bring operational and sales synergies and position Austco to capitalize on new opportunities in the rapidly evolving healthcare technology sector.
As we continue to leverage the strengths of these acquisitions, we expect them to play an even larger role in our long-term growth strategy.In addition,
Austco’s latest product release, Touchpoint, offers a versatile, compact touchscreen solution that can be customized as a Room Information Board, Workflow Terminal, or Active Alarms Display. It Contracted Orders ($m)supports two-way VOIP calling, delivers tones and visuals for remote locations, and operates seamlessly with the Pulse suite of applications, further enhancing Austco’s product portfolio.
Outlook for Austco Healthcare
Austco Healthcare is well-positioned to continue its growth in the year ahead. By strategically enhancing its sales and marketing efforts, particularly in high-growth markets, the Company is poised to seize emerging opportunities in the healthcare technology sector.The Company remains committed to executing its growth-driven strategies, ensuring continued growth into the future to drive long-term value creation for our shareholders.This announcement was approved for release by the AHC Board
i do not hold this share ( and have no order for it currently in the market )
my tip for the November comp.
software services to the healthcare industry , i have had mixed results in this niche
BUT if it dips enough after this ann. i MIGHT dip a toe in the water
the main risks i see are exposure to Canada , and the management getting too ambitious wasting funds on travelling all over trying to get more sales ( and buying too many ‘bolt-ons )
around 20 cents a share i MIGHT be tempted to gamble ( if i get it wrong i might end up positive in the comp. in November )
